Hence, the findings in our study expand the phenotypic spectrum associated with <i>BBS9</i> variants and indicate that variants in this gene should be considered not only in BBS patients but also in individuals with non-syndromic IRD or IRD with very mild extra-ocular manifestations. The gene discussed is BBS9; the disease is Bardet-Biedl syndrome.